| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07:27 | Aktien KW 14 Trump spielt mit den Märkten - Kriegs-Ende oder nicht. News. Mutares. The Platform Group. Fortec. Norma Group. SUSS MicroTec. Pyramid. Nordex. NanoRepro. SFC Energy. 123fahrschule. Masterflex | 1.312 | Nebenwerte Magazin | Aktien - Immer noch Bomben auf den Iran. Trotz ansteigender Kritik und steigenden Preisen für die US-Wähler, Trump bleibt ratlos im Kampf. Am Mittwoch hofften alle auf die "Rede an die Nation". Am Ende... ► Artikel lesen | |
| 10:09 | EQS-News: Heidelberg Pharma AG: Heidelberg Pharma präsentiert Ergebnisse ihrer proprietären ADC-Technologieplattform auf der AACR-Jahrestagung 2026 | 779 | EQS Group (DE) | EQS-News: Heidelberg Pharma AG
/ Schlagwort(e): Wissenschaftl. Publikation
Heidelberg Pharma präsentiert Ergebnisse ihrer proprietären ADC-Technologieplattform auf der AACR-Jahrestagung... ► Artikel lesen | |
| 08:19 | BioNTech vs. Bioxyne: Wenn Forschungs-Riesen pausieren und Small Caps die Prognosen anheben | Small- & Micro Cap Investment | |||
| 08:00 | Cereno Scientific AB: Cereno Scientific Highlights Strategic Value of Meeting Primary Endpoint of Safety and Tolerability of 12-month CS1 Data in PAH | 307 | GlobeNewswire (Europe) | Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today provides additional... ► Artikel lesen | |
| 16:14 | New to The Street Announces Episode 741 Airing Tonight on Bloomberg Television at 6:30 PM EST Featuring Canton Networks, Acme Markets, Virtuix Holdings, HPB, Jonas & Redman, Acurx Pharmaceuticals, and FreeCast | 271 | ACCESS Newswire | NEW YORK CITY, NY / ACCESS Newswire / April 4, 2026 / New to The Street, one of the longest-running U.S. and international business television brands, today announced the broadcast of Episode 741, airing... ► Artikel lesen | |
| Fr | Matinas BioPharma Holdings, Inc.: Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards | 244 | GlobeNewswire (Europe) | BEDMINSTER, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the "Company") (NYSE American: MTNB) announced today that on April 2, 2026, it received a notice (the "Notice")... ► Artikel lesen | |
| Fr | AEON Biopharma Inc: AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards | 209 | GlobeNewswire (Europe) | IRVINE, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. ("AEON" or the "Company") (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 (prabotulinumtoxinA) as a biosimilar... ► Artikel lesen | |
| Fr | Denali Therapeutics Inc.: Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN) | 88 | GlobeNewswire (Europe) | Denali plans to continue clinical development of DNL593, which is designed to deliver progranulin to the brain using TransportVehicle technologyResults from ongoing Phase 1/2 study in patients with... ► Artikel lesen | |
| Fr | Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans | 53 | GlobeNewswire (Europe) | HOUSTON, April 03, 2026 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO) announced that its annual report(10-K) for the fiscal year ending December 31, 2025, filed on March 11, 2026... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| SIGA TECHNOLOGIES | 5,250 | 0,52 | +9,90 % | 0,60 | 07.04.2026 | |
| BB BIOTECH | 47,850 | 2,47 | +5,16 % | 2,25 | 23.03.2026 | |
| CSL | 83,33 | 2,61 | +3,13 % | 1,84 | 10.03.2026 | |
| AMGEN | 301,50 | 8,38 | +2,78 % | 2,52 | 15.05.2026 | |
| RECORDATI | 48,620 | 1,30 | +2,67 % | 0,71 | 18.05.2026 | |
| NOVONESIS | 51,64 | 0,87 | +1,68 % | 4,25 | 20.03.2026 | |
| SINO BIOPHARM | 0,698 | 0,01 | +1,43 % | 0,05 | 24.06.2026 | |
| GENUS | 27,600 | 0,38 | +1,38 % | 0,11 | 05.03.2026 | |
| BIOMERIEUX | 92,60 | 0,90 | +0,97 % | 0,98 | 09.06.2026 | |
| BIO-TECHNE | 45,800 | 0,27 | +0,59 % | 0,08 | 13.02.2026 |